MelaVV™ · Hair Restoration Platform

Immediate coverage. Lasting results.

Treatment you'll actually keep doing.

Two US patent applications pending

Immediate coverage. Lasting results. Nothing to hide.

Problem

Treatments for hair loss work. The clinical evidence is clear and has been for decades. But clinical outcomes depend entirely on whether patients keep using the treatment consistently — and that has always been the real problem.

For many patients — men and women alike — daily topical treatment is visually conspicuous. It changes how hair looks. It changes how hair feels. It is a daily, visible reminder of something most people would rather not think about. They start. They stop. The results never come.

This is not a pharmacology problem. It has never been. The treatments work. The experience of using them, for too many patients, does not.

The gap between what hair restoration treatments can do and what they actually deliver has always been a question of consistent daily use. MelaVV™ was built to close it.

Overview

MelaVV™ delivers immediate, natural-looking results from the very first application — while maintaining continuous therapeutic efficacy. One product. Both outcomes. Designed from the ground up so that staying on treatment is the path of least resistance.

When treatment is invisible, the decision to keep using it disappears.

Solution — What It Delivers

  • Immediate natural coverage from the first application — no visible evidence of treatment, no residue, no change to how hair looks or feels.
  • Continuous therapeutic efficacy maintained through consistent daily use — made possible because daily use is no longer a burden.
  • An experience designed around the patient — not just the condition.
The pull-quote

Not a new molecule. A new patient experience built around the proven molecule.

Most hair restoration treatments ask patients to accept visible evidence of their condition every day. MelaVV™ removes that requirement entirely.

Market

$2.4B

Topical minoxidil market by 2032 — up from $1.1B in 2023 · CAGR 9.1%

$6.1B

Global hair loss treatment market by 2031 — up from $3.8B in 2024 · CAGR 6.9%

Consistent daily use is the dominant clinical challenge across the category. MelaVV™ addresses the market’s largest unmet need: not a new molecule, a new patient experience built around the proven molecule.

Why It’s Different

  • Standard topical treatments are effective but visually conspicuous. MelaVV™ is effective and immediately invisible.
  • Most hair restoration products treat the condition. MelaVV™ treats the condition and the reason patients stop.
  • Existing approaches treat inconsistent use as a behavioral problem. MelaVV™ eliminates it as a design problem.
  • Most treatments require patients to see and feel their condition every day. MelaVV™ removes that experience entirely from day one.
  • Results require consistency. MelaVV™ is the first product in this category designed to make consistency the natural default.

Science Foundation

  • Hair restoration pharmacology
  • Patient behavior and treatment consistency research
  • Cosmetic and therapeutic formulation science
  • Scalp biology and hair growth physiology
  • Patient experience research

Intellectual Property

Two US patent applications pending.

Get in touch

Treatment you'll actually keep doing.

Immediate coverage, lasting results, and nothing to hide.

Connect With Us
Call Us Appointments

Accessibility Tools

Increase TextIncrease Text
Decrease TextDecrease Text
GrayscaleGrayscale
Invert Colors
Readable FontReadable Font
Reset